ABL1 and acute lymphoblastic leukemia: We further checked the effect of dasatinib on JNK activation in a BCR-ABL+ B-ALL mouse model generated by transplantation of BCR-ABLP190-transduced CD19+ bone marrow cells (BMCs) into lethally irradiated recipient mice (Supplementary Fig. S2a and b).